Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Permsuwan U, Niamhun N, Tanatip N, Thongprasert S. Epidermal growth factor receptor mutation testing in Thailand: a cost-utility analysis. Value in Health Regional Issues 2014; 3(1): 39-43 Indexing Status Subject indexing assigned by CRD MeSH Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; DNA Mutational Analysis; Humans; Lung Neoplasms; Mutation; Quinazolines; Receptor, Epidermal Growth Factor; Thailand AccessionNumber 22014018444 Date bibliographic record published 17/10/2014 |
